We are live on ! Find out more
SIM

Sandia Investment Management Portfolio holdings

AUM $40.1M
1-Year Est. Return 13.88%
This Fund
S&P 500
This Quarter Est. Return
+1.11%
1 Year Est. Return
+13.88%
3 Year Est. Return
+19.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$546M
AUM Growth
-$25.3M
Cap. Flow
-$38M
Cap. Flow %
-6.96%
Top 10 Hldgs %
31.2%
Holding
325
New
85
Increased
40
Reduced
25
Closed
92

Top Buys

Rank Stock Value
1
LVRO
Lavoro
LVRO
+$7.84M
2
CIIG
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
+$6.08M
3
TWOA
two
TWOA
+$5.08M
4
EOCW
Elliott Opportunity II Corp.
EOCW
+$4.95M
5
APGB
Apollo Strategic Growth Capital II
APGB
+$4.77M

Top Sells

Rank Stock Value
1
TPBAU
TPB Acquisition Corporation I Unit
TPBAU
+$15.2M
2
AMCIU
AMCI Acquisition Corp II Units
AMCIU
+$14.1M
3
ANZUU
Anzu Special Acquisition Corp I Units
ANZUU
+$11M
4
CPARU
Catalyst Partners Acquisition Corp. Unit
CPARU
+$9.15M
5
CLAA
Colonnade Acquisition Corp. II
CLAA
+$8.64M

Sector Composition

Rank Sector Weight
1 Financials 31.89%
2 Healthcare 4.04%
3 Technology 3.68%
4 Industrials 2.49%
5 Materials 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHACW
176
CALL
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$94.2K 0.02%
554,530
+99,444
+22% +$10.8K
NTST
177
NETSTREIT Corp
NTST
$2.02B
$91.4K 0.02%
5,000
– –
WRAC.WS
178
CALL
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$90.9K 0.02%
1,253,970
+472,397
+60% +$24.3K
GCTS.WS
179
CALL
GCT Semiconductor Holding Warrants
GCTS.WS
$18.8M
$88.2K 0.02%
803,100
+79,400
+11% +$5.43K
SVIIR
180
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$86.2K 0.02%
431,000
– –
JWSM.WS
181
CALL
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$85.7K 0.02%
788,321
+207,620
+36% +$18.7K
JUN.WS
182
CALL
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$83.9K 0.02%
791,838
+150,794
+24% +$25.5K
BBIO icon
183
BridgeBio Pharma
BBIO
$16.4B
$82.9K 0.02%
+5,000
New +$58.3K
ECVT icon
184
Ecovyst
ECVT
$1.11B
$82.9K 0.02%
7,500
-5,000
-40% -$51.7K
VICI icon
185
VICI Properties
VICI
$28.6B
$81.5K 0.01%
+2,500
New +$82.7K
VERA icon
186
Vera Therapeutics
VERA
$2.18B
$77.6K 0.01%
+10,000
New +$77.2K
LNZA icon
187
LanzaTech
LNZA
$69M
$75.8K 0.01%
+195
New +$131K
ROIV icon
188
Roivant Sciences
ROIV
$25.5B
$73.8K 0.01%
+10,000
New +$82.3K
GFX.WS
189
CALL
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$73.6K 0.01%
306,577
+31,778
+12% +$6.24K
GDYN icon
190
Grid Dynamics Holdings
GDYN
$630M
$68.8K 0.01%
6,000
-1,677
-22% -$19.7K
BAERW icon
191
CALL
Bridger Aerospace Warrant
BAERW
$11.2M
$66K 0.01%
+386,884
New +$77.3K
ROSS.WS
192
CALL
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$59K 0.01%
225,246
+4,575
+2% +$997
BRSP
193
BrightSpire Capital
BRSP
$626M
$59K 0.01%
+10,000
New +$68.6K
BLEUR
194
DELISTED
bleuacacia ltd Rights
BLEUR
$54.8K 0.01%
1,778,102
+50,600
+3% +$3.68K
COCHW icon
195
CALL
Envoy Medical Warrant
COCHW
$708K
$53.1K 0.01%
1,507,617
+349,277
+30% +$19.6K
PR
196
Permian Resources
PR
$18B
$52.5K 0.01%
+5,000
New +$51K
TSVT
197
DELISTED
2seventy bio
TSVT
$51K 0.01%
+5,000
New +$57.2K
VBTX
198
DELISTED
Veritex Holdings
VBTX
$45.6K 0.01%
2,500
-5,000
-67% -$127K
PEPLW
199
CALL
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$45.3K 0.01%
476,460
– –
PLMJW
200
CALL
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$43.5K 0.01%
340,021
+67,602
+25% +$6.62K
6 7
8
9 10

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
SPA
Sherbrooke Park Advisers White Plains, New York $38.7M AUM 5.29% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
PP
Prospector Partners Guilford, Connecticut $46.7M AUM 11.1% 1-Year Est. Return
TWP
Total Wealth Planning Cincinnati, Ohio $46.7M AUM 13.43% 1-Year Est. Return

Sandia Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sandia Investment Management held 325 positions worth $546M, down 4.4% from $571M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sandia Investment Management withdrew a net $38M in Q1 2023, closing 92 positions and reducing 25 holdings. Its most notable exit was TPB Acquisition Corporation I Unit, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Sandia Investment Management opened a new position in Lavoro worth $11.2M.

  • Sandia Investment Management's largest Q1 2023 buy was Lavoro: 1,098,250 shares worth $11.2M.
  • Sandia Investment Management added most to Envoy Medical in Q1 2023, an estimated $4.4M increase.
  • Sandia Investment Management's biggest Q1 2023 reduction was PepperLime Health Acquisition Corporation Class A Ordinary Share, cutting an estimated $8.19M.
  • Sandia Investment Management fully exited TPB Acquisition Corporation I Unit in Q1 2023, selling an estimated $15.2M.
  • Sandia Investment Management's ten largest holdings make up 31% of its $546M portfolio in Q1 2023.
  • Sandia Investment Management opened 85 new positions and closed 92 in Q1 2023.
  • Sandia Investment Management's portfolio value fell 4.4% quarter-over-quarter to $546M.

Based on Sandia Investment Management's 13F filing for Q1 2023, filed 15 May 2023.